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Injury to the central nervous system (CNS) results in oligodendrocyte cell death and
progressive demyelination. Demyelinated axons undergo considerable physiological
changes and molecular reorganizations that collectively result in axonal dysfunction,
degeneration and loss of sensory and motor functions. Endogenous adult
oligodendrocyte precursor cells and neural stem/progenitor cells contribute to the
replacement of oligodendrocytes, however, the extent and quality of endogenous
remyelination is suboptimal. Emerging evidence indicates that optimal remyelination
is restricted by multiple factors including (i) low levels of factors that promote
oligodendrogenesis; (ii) cell death among newly generated oligodendrocytes, (iii)
inhibitory factors in the post-injury milieu that impede remyelination, and (iv) deficient
expression of key growth factors essential for proper re-construction of a highly
organized myelin sheath. Considering these challenges, over the past several years,
a number of cell-based strategies have been developed to optimize remyelination
therapeutically. Outcomes of these basic and preclinical discoveries are promising and
signify the importance of remyelination as a mechanism for improving functions in
CNS injuries. In this review, we provide an overview on: (1) the precise organization
of myelinated axons and the reciprocal axo-myelin interactions that warrant properly
balanced physiological activities within the CNS; (2) underlying cause of demyelination
and the structural and functional consequences of demyelination in axons following
injury and disease; (3) the endogenous mechanisms of oligodendrocyte replacement;
(4) the modulatory role of reactive astrocytes and inflammatory cells in remyelination;
and (5) the current status of cell-based therapies for promoting remyelination. Careful
elucidation of the cellular and molecular mechanisms of demyelination in the pathologic
CNS is a key to better understanding the impact of remyelination for CNS repair.
Keywords: demyelination, spinal cord injury, cell therapy, oligodendrocytes, remyelination, neural stem cells,
oligodendrocyte precursor cells, astrocytes
Introduction
Myelin is a cholesterol rich extension of oligodendrocytes and Schwann cells (SCs) plasma
membrane, which serves as a specialized insulation sheath for axons in the nervous system.
Myelin facilitates axon signal conduction through enabling “saltatory conduction” (see review by
Miron and Franklin, 2014). However, the importance of myelin in the central nervous system
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(CNS) is beyond its role in rapid signal conduction along
axons as its disturbance also cause other severe functional and
neurobehavioral disabilities (as reviewed by Love, 2006). Myelin
is important for axon maintenance and function (Nave and
Trapp, 2008). Perturbations of myelin structure and function
or “demyelination” is associated with a long list of CNS
pathologies from congenital and autoimmune disorders to
metabolic disturbances (Love, 2006). Progressive demyelination
also results in axonal degeneration due to the disruption of
axo-oligodendrocyte signaling. A healthy cross talk between
axons and oligodendrocytes is required to maintain proper
metabolic function of axons, trophic support, cytoskeletal
arrangement, ion channel organization, and axonal transport
(Edgar et al., 2004; Devaux and Scherer, 2005; Kassmann and
Nave, 2008; Nave and Trapp, 2008; Bruce et al., 2010; Nave,
2010; Fünfschilling et al., 2012). Axons become dependent on
myelinating glia as myelin appears during the development.
This concept was demonstrated in PLP/DM20 deﬁcient mice
where the absence of these essential myelin proteolipids
resulted in axonal swellings only in myelinated axons with
no evidence of axonal pathology in normal unmyelinated
ﬁbers (Griﬃths et al., 1998). Moreover; mice lacking Cnp1,
which encodes 2′,3′-cyclic nucleotide phosphodiesterase in
oligodendrocytes, show no structural abnormality in myelin
but develop axonal swelling and degeneration (Lappe-Siefke
et al., 2003). These studies suggest that myelinated axons receive
signals from oligodendrocytes that trigger their dependency
to myelin. Interestingly, such a dependency have not yet
been observe in non-myelinated axons (Griﬃths et al., 1998;
Lappe-Siefke et al., 2003). Survival of oligodendrocytes is
also dependent on axons. Following injury, oligodendrocytes
distal to the site of an axonal injury degenerate due to
lack of trophic support from the injured axon (Lappe-Siefke
et al., 2003). Considering the reciprocal axo-oligodendrocytes
signaling, replacement of oligodendrocytes and renewal of myelin
sheath around surviving demyelinated axons following injury
is a vital repair strategy for CNS regeneration and functional
recovery.
Oligodendrocyte precursor cells (OPCs) and neural
stem/progenitor cells (NPCs) are two endogenous cell
populations, capable of replacing lost oligodendrocytes and
remyelinating spared axons following injury (Beattie et al., 1997;
Eftekharpour et al., 2008; Meletis et al., 2008; Barnabe-Heider
et al., 2010). Despite the spontaneous response and activation
of both OPCs and NPCs upon injury, adequacy, and quality of
remyelination is challenged due to multiple factors including
modiﬁcations in the extracellular matrix, astrogliosis, and
downregulation of essential trophic and growth factors (Karimi-
Abdolrezaee et al., 2006; Meletis et al., 2008; Barnabe-Heider
et al., 2010; Karimi-Abdolrezaee et al., 2012; Lau et al., 2012;
Gauthier et al., 2013; Lukovic et al., 2015). These injury-induced
events either limit oligodendrocyte diﬀerentiation or impede
the process of axonal ensheathment and remyelination. Over
the last decade, cellular and pharmacological repair strategies
have been developed to induce remyelination by recruiting
endogenous precursor cells or through stem cell therapies
(Karimi-Abdolrezaee et al., 2006; Eftekharpour et al., 2007, 2008;
Joubert et al., 2010; Kotter et al., 2011; Karimi-Abdolrezaee and
Eftekharpour, 2012; Rodgers et al., 2013; Plemel et al., 2014).
In this review, (1) we will provide an overview on the precise
molecular and ion channel organization of myelinated axons
and the reciprocal axo-myelin interactions that warrant properly
balanced physiological activities within the CNS, (2) we will
dissect the underlying cause of demyelination and the structural
and functional consequences of demyelination in axons by
focusing on spinal cord injury (SCI) and multiple sclerosis
(MS) models, (3) we will discuss the role of activated glia in
demyelination and remyelination following demyelination, and
(4) we will review the current status of cell-based therapeutic
interventions that are designed to promote oligodendrocyte
diﬀerentiation and facilitate remyelination. Understanding the
functional ramiﬁcation of demyelination and remyelination
and the cellular and molecular basis of these events will aid
in developing targeted therapies to more eﬀectively promote
myelin repair and prevent disease progression in demyelinating
conditions.
Normal Molecular Organization of Myelin
and Nodes of Ranvier
Myelin is a modiﬁed plasma membrane of oligodendrocytes in
the CNS, which enwraps a segment of axon in a spiral fashion
(Barres et al., 1993). Myelination aﬀects function and molecular
organization of axons allowing faster signal propagation with
reduced energy consumption (Frankenhaeuser and Schneider,
1951; Bishop and Levick, 1956; Homma et al., 1983; Saab et al.,
2013; Stiefel et al., 2013). Several proteins in myelin have been
identiﬁed to play essential roles in axonal maintenance and
function. Proteolipid protein (PLP) and its spliced derivative,
DM20, are essential for proper axonal function (Griﬃths
et al., 1998; Lappe-Siefke et al., 2003). Loss of either PLP or
DM20 will aﬀect myelin periodicity and cause axonal swelling
(Griﬃths et al., 1998; Lappe-Siefke et al., 2003). Swollen axons
will gradually become dysfunctional and degenerate causing
functional deﬁcits at later stages (Griﬃths et al., 1998). Myelin
basic protein (MBP) is another structural protein that plays a vital
role inmyelin compaction and thickening in the CNS (Condorelli
et al., 2003; Eftekharpour et al., 2007). Shiverer mice that lack
MBP demonstrate dysmyelinated axons associated with axonal
dysfunction and motor impairments (Loers et al., 2004; Sinha
et al., 2006). Interestingly, Shiverer mice do not develop axonal
swelling and show minimal axonal degeneration compared to
PLP/DM20 deﬁcient mice even up to 2–3 months following
birth (Griﬃths et al., 1998; Loers et al., 2004). Myelin associated
glycoprotein (MAG) is essential for the initiation of myelination
(Biﬃger et al., 2000). Mice with double knockout of MAG and
Fyn (a downstream signaling molecule in MAG/Fyn pathway)
demonstrate severe optic nerve hypomyelination despite the
unaﬀected presence of oligodendrocytes (Biﬃger et al., 2000).
MAG is also known to be essential for survival and integrity
of myelinated axons (Yin et al., 1998; Pan et al., 2005; Nguyen
et al., 2009), however, such a role has not been established
for Fyn (Biﬃger et al., 2000). CNPase (2,3-cyclic nucleotide
Frontiers in Molecular Neuroscience | www.frontiersin.org 2 July 2015 | Volume 8 | Article 35
Alizadeh et al. Myelin damage and repair in pathologic CNS
3-phosphodiesterase) is an enzyme that is synthesized in
myelinating mature oligodendrocytes and can be found in non-
compact regions of the myelin sheath (Nagy et al., 1997). Lack of
CNPase has not been shown to aﬀect myelination but myelinated
axons will eventually become swollen and degenerate (Lappe-
Siefke et al., 2003; Rocco et al., 2004). This evidence demonstrates
the importance of the various myelin compartments/proteins for
the proper functioning of axons and oligodendrocytes. However,
further investigations are required to elucidate the role of each
myelin protein in this complex relationship.
Myelinated axons show a high degree of structural
organization. A myelinated axon can be separated into distinct
domains including node of Ranvier, paranode, juxtaparanode,
and internode (Eftekharpour et al., 2008; Ohno et al., 2014;
Plemel et al., 2014) (Figure 1A). Node of Ranvier is the
gap between two adjacent myelin sheaths and contains high
concentrations of voltage-dependent Na+ channels on the
axonal membrane (Amor et al., 2014). Electrical impulse cannot
ﬂow through the high resistance myelin sheath, but instead
ﬂows through the node of Ranvier and depolarizes the axonal
membrane at each node resulting in saltatory conduction (Ohno
et al., 2011).
In myelinated axons, node of Ranvier was characterized by
the localization of voltage-gated sodium (Nav) and KCNQ K+
channels (Chiu and Ritchie, 1980; Rasband et al., 1998). Node
of Ranvier also contains a collection of adhesion molecules,
adaptor proteins, and cytoskeletal structures including, βIV-
spectrin, ankyrin G, neuron-glia-related cell adhesion molecule
(NrCAM) and a 186 kDa isoform of neurofascin (NF186) (Davis
et al., 1996; Salzer, 2003; Amor et al., 2014) (Figure 1A). Among
these molecules, βIV-spectrin and ankyrin G play a major role
in stabilizing the Nav channels at nodal region (Lai and Jan,
2006). During the development of axons, Nav1.2 channels are
initially expressed along pre-myelinated axons with the capability
to generate an action potential (Caldwell et al., 2000; Rasband
and Shrager, 2000). As myelination ensues, Nav 1.6 channels
begin to cluster at mature nodes of Ranvier (Boiko et al., 2001;
Kaplan et al., 2001). Nav1.2 and Nav1.6 channels are both rapidly
activating and inactivating channels but Nav1.6 is known to
produce a larger persistent current (Caldwell et al., 2000; Rush
et al., 2005). Glial cells play an essential role in the formation
of normal nodes of Ranvier with their typical nodal Nav and
paranodal Kv channel distribution. As it has been reviewed
by Schafer and Rasband (2006), there are similarities in the
contribution of glial cells in node formation between the CNS
and PNS. In both systems glial cell adhesion molecules (CAMs)
in close association with axonal CAMs and cytoskeletal domain,
form a structural framework that clusters ion channels with
speciﬁc formation in nodal and paranodal areas (Schafer and
Rasband, 2006) (see Figure 1A).
Paranode is the adjacent segment to the node of Ranvier where
myelin loops provide an anchor by tethering the myelin to the
axonal membrane (Poliak et al., 1999). Evidence has established
a determining role for paranodal axo-oligodendrocyte junction
in precise localization of ion channels into specialized domains
of myelinated axons (Barres et al., 1992a,b; Davis et al., 1996;
Kiernan et al., 1996; Kaplan et al., 1997). Paranodal junctions are
critical in preventing lateral diﬀusion of ion channels along the
axons to ensure proper segregation of Na+ and K+ channels at
discrete domains on axonal membrane (Gard et al., 1995; Peles
and Salzer, 2000). The paranodal region was characterized by the
presence of Contactin and Contactin-Associated Protein (Caspr)
that form a complex in the “septate-like junctions” between
myelin loops and axolemma (Einheber et al., 1997). Caspr is
critical for the establishment of axo-glia junction in myelinated
ﬁbers through its interactions with contactin and NF-155 (Lyons
and Talbot, 2008). Caspr deﬁciency results in disruption of the
paranodal region and aberrant distribution of ion channels along
the axons (Kiernan et al., 1996) (see Figure 1A).
The juxtaparanode contains delayed-rectiﬁer voltage-gated
Kv+ channels and Na+/K+ ATPase channels that allow for rapid
exchange of axoplasmic Na+ for extracellular K+ and restoration
of the resting membrane potential (Poliak et al., 2003; Traka
et al., 2003). As ion channel clustering evolves, shaker type Kv1.1
and Kv1.2 channels begin to localize in juxtaparanodal region of
the myelinated axons (Wang et al., 1993; Rasband et al., 1998).
These channels are associated with the Caspr2/TAG-1 adhesion
complex (Poliak et al., 1999, 2003; Traka et al., 2002, 2003;
Horresh et al., 2008) (Figure 1A). Upon receiving of an action
potential, Nav channels open, allowing an inﬂux of Na+ into the
axon causing depolarization. After each depolarization, Na+/K+
ATPase pumps, located at the juxtaparanodal and internodal
regions, exchange axonal Na+ for extracellular K+ (Meta et al.,
1991). This process is an energy dependent mechanism and
is essential for rapid and repetitive axonal ﬁring. Similarities
exist between the molecular organization of nodes and the axon
initial segment; however, while myelin is crucial for the proper
molecular organization of nodes, the axon initial segment appears
to be intrinsically organized by the neuron (Dzhashiashvili et al.,
2007; Yang et al., 2007). Evidence from our group and others
have shown that demyelination due to injury and disease results
in disruption of the precise nodal organization causing axonal
dysfunction (Davis et al., 1996; Kaplan et al., 1997; Nashmi
et al., 2000; Karimi-Abdolrezaee et al., 2004; Eftekharpour et al.,
2005, 2007; Sinha et al., 2006). Additionally, myelination provides
extrinsic trophic signals, which inﬂuence the normal maturation,
maintenance, and long-term survival of axons (White et al., 2009;
Mar and Noetzel, 2010; Castelvetri et al., 2011; Lassmann et al.,
2012; Mekhail et al., 2012; Teixeira et al., 2014). Structural and
functional importance of nodal organization will be discussed in
subsequent sections.
Demyelination and Its
Pathophysiological Consequences
Demyelination is damage or loss of the myelin sheath around
axons. It is mainly a consequence of oligodendroglia cell death
that can occur through multiple mechanisms depending on the
type of disease or injury, including genetic defects, infectious
agents, autoimmune reactions, trauma, and some by unknown
mechanisms (Zimmerman, 1956; Popescu and Lucchinetti, 2012;
Kutzelnigg and Lassmann, 2014). Several genetic disorders exist
that can cause defects in myelin through improper myelination
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FIGURE 1 | Structural and molecular organization of myelinated axons
in normal and demyelinating conditions. (A) Schematic diagram shows
structure and molecular configuration of a myelinated axon at the node of
Ranvier, paranodal and juxtaparanodal regions. Nav 1.6 and Kv7 (KCQN) are
located in the nodal region and are essential for formation and propagation
of action potential. Na+/Ca2+ exchanger (NCX) is also located in nodal area
and exchanges intracellular sodium with extracellular Ca2+ in an ATP
dependent manner. Ion channels are precisely localized to specific domains
of axons through their contact with adhesion molecules such as neurofascin
(NF)-186. These adhesion molecules aid in stabilizing ion channels by
connecting them with extracellular matrix (ECM) and glial cell processes
surrounding the nodal region. Paranodal junctions are the region where
myelin loops are tethered to axonal membranes. Contactin and contactin
associated protein (Caspr) play key roles in formation of paranodal loops
through their interaction with neurofascin (NF)-155 and other adhesion
molecules from myelinating glia. Juxtaparanode contains voltage gated Kv+
channels (Kv1.1 and 1.2) that are essential for restoring resting membrane
potential. Kv channels allow for potassium to exit the axons quickly following
depolarization. Caspr2/TAG-1 adhesion complex stabilizes these Kv1.1 and
Kv1.2 channels in axonal membrane. Stationary mitochondria (brown) are
mainly located in juxtaparanodal and internodal regions where Na/K ATPases
are abundant to provide energy for ion homeostasis. There is another
mitochondrial population called motile mitochondria (green) which can
translocate in both retrograde and anterograde directions along the axon.
These mitochondria are being produced in the cell body and can stop in
stationary sites. They are important for the turnover and redistribution of
mitochondria along the axons and during changes in energy demand.
(B) Following demyelination, due to the disruption of paranodal myelin loops,
all ion channels, pumps and exchangers become dispersed along the axon
and sodium influx increases through Nav1.6 channels. Expression of Nav1.6,
Kv1.1, and Kv1.2 channels increases significantly following demyelination.
Sodium overload causes axonal calcium to reach toxic levels as it is being
exchanged with sodium through NCXs by an energy dependent process.
Following demyelination, speed of mitochondrial transportation and size of
stationary mitochondria significantly increase to compensate for the increased
energy demand. Despite robust increase in mitochondrial content,
demyelinated axons are unable to maintain a balance between their energy
production and expenditure that results in axonal degeneration eventually.
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and myelin maintenance or progressive demyelination over time.
Charcot-Marie-Tooth disease (CMT), Alexander disease, and
Krabbe disease are examples of the many known genetic diseases
characterized by axonal demyelination or dysmyelination (Ida
et al., 1990; Satoh et al., 1997; Rocco et al., 2004; da Silva Pereira
et al., 2013; Perveen et al., 2015).
Multiple Sclerosis is a classic example of autoimmune
demyelination in the CNS (Bitsch et al., 2000; Kuhlmann
et al., 2008). The early stages of MS involve relapsing-remitting
where patient experience demyelination associated with loss
of function (i.e., vision and gait), which is usually regained
following remyelination. In the progressive stages of MS,
irreversible functional deﬁcit occurs which has been associated
with progressive loss of axons and neurons (Kurtzke et al., 1977;
Flachenecker and Hartung, 1996). Degeneration of chronically
demyelinated axons is now considered to be a major contributor
to the permanent neurological disability that MS patients
eventually endure (Saito et al., 1990; Bjartmar and Trapp, 2001,
2003; Stys, 2004; Su et al., 2009; Dziedzic et al., 2010; Cambron
et al., 2012).
Demyelination can also occur through traumatic injury. In
the chronically injured spinal cord, there is varying degree
of demyelination and dysmyelination in the subpial rim
surrounding the lesion site (Nashmi and Fehlings, 2001).
Following SCI, some axons and oligodendrocytes are initially
lost through necrosis due to mechanical injury. As injury
evolves, progressive loss of oligodendrocytes occurs through
apoptosis and autophagy that results in demyelination of injured
spared axons (Abe et al., 1999; Casha et al., 2001; McTigue
and Tripathi, 2008; Kanno et al., 2009; Plemel et al., 2014).
Remyelination occurs spontaneously by both OPCs and NPCs
following injury even in the chronically injured spinal cord
(Beattie et al., 1997; Salgado-Ceballos et al., 1998; Hesp et al.,
2015). However, this remyelination attempt is often limited
and inadequate due to changes to the post-injury environment
(Barnabe-Heider et al., 2010; Karimi-Abdolrezaee et al., 2010,
2012; Xing et al., 2014; Hesp et al., 2015). Therapeutic strategies
aimed at promoting remyelination have demonstrated the
potential to promote axonal sparing and limit progressive
axonal dieback in chronic SCI (Karimi-Abdolrezaee et al.,
2010).
Animal models of demyelinating disease such as MS
provide invaluable tools to study myelin–axon interactions and
understand the pathological eﬀects of demyelination on axonal
integrity and function. Here, we will primarily focus on the
eﬀects of demyelination on axons in models of MS and SCI,
however, many of the details provided here also correlate
with other ﬁndings in the literature in other demyelinating
conditions.
Changes to Ion Channels Following
Demyelination
Loss of myelin sheath causes aberrant distribution of ion
channels, where Nav channels diﬀuse away from the nodes and
redistribute across the axonal surface (Waxman et al., 2004).
Additionally, there appears to be an overall increase in the
expression of Nav channels in chronically demyelinated axons
(Bostock and Sears, 1978; Foster et al., 1980; Waxman et al.,
2004). Following experimental autoimmune encephalomyelitis
(EAE), Nav1.2, and Nav1.6 channels are up-regulated in
demyelinated axons (Craner et al., 2003, 2004a) (see Figure 1B).
Sodium channel redistribution causes an overall increase in Na+
inﬂux during impulse conduction and increased demand for
ATP during repolarization (Waxman et al., 2004). Furthermore,
increased sodium inﬂux has been associated with axonal
degeneration through a Ca2+-mediated eﬀect by causing the
reversal of the Na+/Ca2+ exchanger (NCX) (Stys et al., 1992;
Figure 1). Inhibition of sodium channels and NCX has been
shown to prevent axonal degeneration (Rosenberg et al., 1999;
Bechtold et al., 2004; Hains et al., 2004). Increased axonal
Ca2+ can activate proteolytic enzymes and eventually lead to
degeneration of chronically demyelinated axons (Stys et al.,
1992). Ca2+ inﬂux is not normally toxic in axons, however,
increased energy demand and thus lack of ATP in axons following
demyelination causes failure in the energy-dependent Ca2+
buﬀering system to eﬃciently remove excess Ca2+. This results
in a rise in the Ca2+ concentration to toxic levels (Stys and
Lopachin, 1998; Trapp and Stys, 2009; Plemel et al., 2014). Lack
of ATP in chronically demyelinated axons is thought to render
axons vulnerable to cellular death over time (Stys, 1998).
Axonal degeneration caused by sodium inﬂux is thought to
be mainly mediated through Nav1.6 channels. Nav1.6 channels
produce a persistent current, which is much larger than that
of Nav1.2 (Smith et al., 1998). Nav1.6 has been shown to be
co-localized with NCX following demyelination of axons in
EAE model (Craner et al., 2004a) and in postmortem cervical
spinal cord and optic nerve tissue of acute MS patients (Craner
et al., 2004b). Nav1.6 is co-localized in 60% of axons, which
express β-amyloid precursor protein (APP), a marker for axonal
injury, whereas it is only expressed in 20% of axons, which
are β-APP negative (Craner et al., 2004b). Importantly, in
chronic lesions of MS, Nav1.6 is expressed in patches in only
a third of axons (Black et al., 2007). Evidence shows that
demyelinated axons are more susceptible to axonal injury than
dysmyelinated axons, which may be explained by the altered
expression of Nav1.6. Dysmyelination in MBP−/− Shiverer mice
have altered expression of Nav channels in their axons with
Nav1.2 being retained into adulthood and Nav1.6 not being
expressed (Boiko et al., 2001). Similarly, PLP−/− mice also
show a loss of Nav1.6 channel clustering and an increased
expression of Nav1.2 (Rasband et al., 2003). Because Nav1.2
channels are expressed in pre-myelinated axons and can produce
signals, it is believed that newly produced Nav1.2 channels
support conduction in demyelinated axons (Craner et al.,
2004b).
Juxtaparanodal voltage-gated Kv+ channels are also
inﬂuenced by demyelination after SCI or genetic dysmyelination
(Nashmi et al., 2000; Karimi-Abdolrezaee et al., 2004;
Eftekharpour et al., 2005, 2007). We have shown that spinal
cord axons in dysmyelinated Shiverer mice exhibit a dispersed
distribution of Kv+ channel subunits Kv1.1 and Kv1.2 associated
with the loss of the characteristics of juxtaparanodal and
paranodal structures (Eftekharpour et al., 2007) (Figure 1B).
Our investigations on dysmyelinated Shiverer mice and Long
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Evans Shaker (LES) rats elucidated the role of K+ channels in
axonal function (Eftekharpour et al., 2005; Sinha et al., 2006).
These studies revealed aberrant localization and increased
expression of both Kv1.1 and Kv1.2 channel subunits along
axolemma of dysmyelinated axons while these channels were
conﬁned to juxtaparanodal regions of the wild-type axons. Using
sucrose gap recording of spinal cord monophasic compound
action potentials (CAP), we demonstrated that Shiverer spinal
cord axons have signiﬁcantly lower CAP amplitude and area
compared to wild-type counterparts (Sinha et al., 2006). Kv+
channel blockage by speciﬁc (DTX-I, DTX-K) and non-speciﬁc
(4-AP) blockers improved axonal conductance; however, this
eﬀect was shown to be more dependent on a combination of
subunits as a speciﬁc blocker of Kv1.1 failed to improve axonal
conduction signiﬁcantly (Sinha et al., 2006). Interestingly, Kv+
channels are also important for remyelination (Bacia et al., 2004).
Administration 4-aminopyridine (4-AP), a broad-spectrum K+
channel antagonist that blocks fast K+ channels, to a mouse
model of cuprizone-induced demyelination, resulted in impaired
oligodendrocyte regeneration and remyelination (Bacia et al.,
2004). These studies collectively demonstrate the pivotal role
of axo-myelin interactions in ion channels distributions and
functions and more importantly on axonal physiology.
Effect of Demyelination on Axonal Transport
and Metabolism
Axonal transport shuttles critical cell body-derived components
back and forth between the soma and axon and across synapses
in neurons (Millecamps and Julien, 2013). Dysfunction of axonal
transport causes neuronal homeostasis imbalance and as a result
makes axons more susceptible to axonal degeneration. Axonal
transport disturbances are thought to precede the initiation
of neurodegeneration in diseases including, hereditary spastic
paraplegias (HSPs), AD and Huntington’s disease (Gunawardena
et al., 2003; Ebbing et al., 2008; Millecamps and Julien, 2013).
Accumulation of APP is known as; an early marker of injury in
MS patients and is believed to accumulate due to lack of axonal
transport following injury (Ferguson et al., 1997; Smith et al.,
2003).
Oligodendrocytes and their myelin sheath are critical in
regulating slow and fast anterograde transport rates (Kirkpatrick
et al., 2001; Edgar et al., 2004). Reduced fast axonal transport
can cause degeneration in distal parts of the axons as observed
in X-linked spastic paraplegia type 2, which is caused by a
mutation of the PLP1 gene, a major protein of the myelin sheath.
Absence of PLP causes swelling of axons and deﬁcits in retrograde
and anterograde transport (Griﬃths et al., 1998; Edgar et al.,
2004). In both humans and mice, absence of PLP causes selective
axonal degeneration of long tracts including the fasciculus gracilis
and distal corticospinal tracts (Garbem et al., 2002). Conversely,
Shiverer mice, lacking MBP, demonstrate a signiﬁcant increase
in slow axonal transport associated with increased density and
instability of microtubules in axons (Kirkpatrick et al., 2001).
Demyelination-induced defects in axonal transport has been
also detected in MS models (Lin et al., 2014; Sorbara et al.,
2014). Studies in an EAE model of optic neuritis in rats suggest
that the extent of disruption in axonal transport appear to be
correlated with the severity of inﬂammation, demyelination,
and axonal injury (Lin et al., 2014). Live imaging of individual
axonal organelles in the spinal cord of mice with acute
EAE revealed that the anterograde and retrograde transport
of mitochondria and peroxisomes were markedly reduced in
spinal axons, which passed through the lesion (Sorbara et al.,
2014). In chronic model of MS, when axonal transport is
restricted, there is reduced density in distal organelles which
can ultimately lead to “starvation” of distal axonal arbors and
axonal degeneration (Sorbara et al., 2014). Transport deﬁcits were
shown to occur prior to any marked alteration of microtubule
tracks (Sorbara et al., 2014). Dysfunction of axonal transport
recovers within days following insult. However, in chronic MS
lesions, transport deﬁcits were apparent resulting in lack of
distal organelle supply (Sorbara et al., 2014). Reduced axonal
transport has been attributed to reactive oxygen and nitrogen
species released by immune cells, which alters the attachment
of motor/cargo complexes to microtubules (Sorbara et al.,
2014). In chronic MS models, anterograde transport from
the soma to the synapses appears to be considerably aﬀected
resulting in reduced organelle transport from cell body to
the axonal terminal at synapses (Sorbara et al., 2014). Hence,
interventions to restore transport tracks and axonal transport
seem to be vital strategies to slow down the progression
of axonal degeneration and reverse these degenerative eﬀects
(d’Ydewalle et al., 2011; Denton et al., 2014; Sorbara et al.,
2014).
The majority of white matter tract axons were entirely
enwrapped by myelin; therefore, it is likely that axons cannot
obtain proper nutrient support from their external environment
on their own and require metabolic support from glial cells
(Saab et al., 2013). It is currently unknown whether glucose
transporters are present at the node of Ranvier (Saab et al.,
2013). In axons, the highest energy requirement occurs at the
Na+/K+ ATPase pump, which is located along the internodes
(Meta et al., 1991). It is proposed that axons receive their
metabolic support mainly through the “pan-glial” network of
oligodendrocytes and astrocytes (Saab et al., 2013). Astrocytes
were further connected to the blood–brain-barrier and to the
nutritive support by brain capillaries (Karimi-Abdolrezaee and
Billakanti, 2012). Oligodendrocytes, expressing connexin (Cx)
47, were coupled to astrocytes, expressing Cx30, through gap-
junctions (Tress et al., 2012). Double KO mice of Cx47 and
Cx30 results in axonal loss, and death in mice (Tress et al.,
2012). This evidence suggests that myelination has a dual role in
supporting the metabolic activity of neurons by saving energy of
axons through saltatory conduction and providing nutrients to
neurons.
Ensheathment of axons by oligodendrocytes are shown
to drastically diminish the ATP consumption of neurons by
reducing the energy required by axons to transmit signals over
long distances through saltatory conduction (Barron et al.,
2004). However, is it important to take into consideration that
the metabolic cost of myelin synthesis and maintenance might
be higher than the saved energy (Harris and Attwell, 2012).
Nonetheless, myelin does save the amount of energy required
in neurons by decreasing the energy expenditure required to
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maintain its resting membrane potential and to propagate
signals (Saab et al., 2013). Following demyelination, there is
an overall increased demand for ATP (Andrews et al., 2006).
The energy required to maintain the intra-axonal ionic balance
and the resting membrane potential by the Na+/K+ ATPase
pump were increased, due to redistribution and an overall
increase in the number of Na+ channels (Craner et al., 2004a;
Black et al., 2007). Shiverer mice exhibit a signiﬁcant change
in the density and activity of mitochondria in their axons
in comparison to wild type animals (Andrews et al., 2006).
Similarly, unmyelinated segments of retinal ganglion cell axons
in the lamina cribrosa also show increased metabolic activity
in comparison to myelinated segments (Bristow et al., 2002;
Barron et al., 2004). Increased metabolism requirements for
demyelinated axons may make these axons more susceptible
to death through disease mechanisms such as inﬂammation
(Millecamps and Julien, 2013).
Mitochondria are the major source of axonal ATP and
play a critical role in apoptosis, reactive oxygen species
generation and calcium buﬀering (Sheng and Cai, 2012).
Two separate populations of mitochondria exist in myelinated
axons, stationary and motile mitochondria. The majority of
mitochondria are located throughout the axons in stationary
sites where multiple mitochondria reside (Ohno et al., 2011;
Saxton and Hollenbeck, 2012). Stationary mitochondrial are
predominantly located in juxtaparanodal/internodal axoplasm,
containing multiple morphologies of varying length, whereas
those located in the nodes/paranodal axoplasm appear uniformly
short or absent altogether (Ohno et al., 2011). Energy
consumption in axons is highest at the juxtaparanodal and
internodal regions where Na+/K+ ATPases are abundantly
present (Meta et al., 1991). These stationary mitochondria do not
translocate and usually vary in length but typically contain the
same diameter throughout the population (Ohno et al., 2011).
A separate population of relatively small but motile mitochondria
also exist which translocate in both anterograde and retrograde
directions (Detmer and Chan, 2007). These motile mitochondria
are produced in the cell body, and can stop within stationary
sites. They are essential for the turnover and redistribution
of mitochondria and have been shown to fuse with or bud
from stationary mitochondria (Detmer and Chan, 2007; Berman
et al., 2009; Sheng and Cai, 2012). The rate of transport and
docking of thesemotile mitochondria can be inﬂuenced by axonal
metabolic demand, such as increases in axonal ﬁring (Ohno et al.,
2011).
Recent evidence has shed some light onto the changes that
occur to mitochondria in the acute stages of demyelination.
Following demyelination there is an overall increased demand
for ATP mainly due to changes in ionic homeostasis (Barron
et al., 2004). Moreover, the size of stationary sites and the speed
of mitochondrial transport is increased in demyelinated axons
(Kiryu-Seo et al., 2010). In vitro studies on myelinated rat dorsal
root ganglion (DRG) axons showed 2.2-fold increase in the size of
stationary mitochondria sites and 47% increase in the velocity of
motile mitochondria following demyelination (Kiryu-Seo et al.,
2010). This response is shown to be an axonal response to
the increased ATP demand of demyelinated axons mediated, at
least partially, through activating transcription factor 3 (Kiryu-
Seo et al., 2010). Increased volume of mitochondria at these
stationary sites are shown to be a protective response by
demyelinated axons mediated through syntaphilin, a protein,
which tethers mitochondria to microtubules at stationary sites
(Ohno et al., 2014). Chronically demyelinated axons exhibit
increased expression of syntaphilin (Mahad et al., 2009).
Demyelinated axons deﬁcient in syntaphilin degenerate at a
signiﬁcantly greater rate than wild type axons associated with
smaller increases in stationary mitochondrial volume indicating
the importance of mitochondrial migration to these stationary
sites (Ohno et al., 2014). In summary, increasing mitochondrial
stationary site size is important in protecting neurons from
degeneration following CNS demyelination (Kiryu-Seo et al.,
2010; Ohno et al., 2014).
Despite this protective response from axons, mitochondrial
function appears to be limited in chronically demyelinated
lesions of MS (Sheng and Cai, 2012). Following demyelination,
changes to the energy balance in axons and dysfunctions of
axonal mitochondria contribute to degeneration of chronically
demyelinated axons (Sheng and Cai, 2012). There appears to be
an overall decrease in the ability of neurons to produce ATP
through their mitochondria (Dutta et al., 2006; Mahad et al.,
2009; Campbell et al., 2011). In postmortem MS tissues, there
was a decreased expression of mitochondrial electron transport
chain genes which was associated with decreased ability of
mitochondria to exchange electrons in respiratory chain complex
I, III (Dutta et al., 2006), and IV (Mahad et al., 2009). This
decrease in respiration was later shown to be mediated through
deletion of mitochondrial DNA in axons (Campbell et al.,
2011). These data suggest that mitochondria in the chronically
demyelinated axons have a reduced ability to produce ATP, which
can contribute to the axonal degeneration over time.
Endogenous Oligodendrocyte
Replacement and Remyelination
Following SCI
It is well-known that spontaneous remyelination occurs naturally
after CNS injury (Gensert and Goldman, 1997; Salgado-
Ceballos et al., 1998). However, the extent and quality of
remyelination is limited following injury resulting in limited
reorganization of nodes of Ranvier and continued axonal
dysfunction (Nashmi et al., 2000; Karimi-Abdolrezaee et al.,
2004, 2006). In rat compressive chronic SCI, we found
considerable number of chronically injured axons in the rim
of white matter that exhibited aberrant distribution of Kv1.1,
Kv1.2, and Caspr along the paranodal and juxtaparanodal
regions, an established characteristic of axonal demyelination or
dysmyelination (Nashmi et al., 2000; Karimi-Abdolrezaee et al.,
2004). Additionally, electron micrographs of the injured white
matter showed that the spontaneous remyelination after SCI is
suboptimal and incomplete as the newly formed myelin around
the injured axons is thinner than normally myelinated axons
(Nashmi and Fehlings, 2001; Karimi-Abdolrezaee et al., 2006).
Considerable evidence over the past years has uncovered that
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failure of the injured and diseased spinal cord for adequate
remyelination is attributed to multiple factors that include
(1) the limited replacement of myelinating oligodendrocytes
by spinal cord progenitor cells (Mothe and Tator, 2005;
Meletis et al., 2008; Barnabe-Heider et al., 2010; Karimi-
Abdolrezaee et al., 2012; Gauthier et al., 2013), (2) insuﬃcient
levels of key growth factors for oligodendrocyte maturation
and myelination (Kakinuma et al., 2004; Almad et al., 2011;
Gauthier et al., 2013), (3) inadequate clearance of myelin
debris that interferes with the process of axonal ensheathment
and remyelination (Naumann et al., 2003; Miron et al., 2011;
Lampron et al., 2015), (4) inhibitory factors mainly driven
by activated glia that inhibit migration and maturation of
OPCs, diﬀerentiation of NPCs to oligodendrocytes, and axonal
ensheathment (Larsen et al., 2003; Kuhlmann et al., 2008;
Karimi-Abdolrezaee et al., 2010; Lukovic et al., 2015). In the
following sections, we will discuss endogenous mechanisms
of remyelination and the role of injury microenvironment in
modulating the replacement of oligodendrocytes and axonal
remyelination.
Replacement of New Myelinating Cells
Following SCI
Spinal cord injury results in loss of oligodendrocyte population
acutely due to necrosis caused by the primary tissue damage
(Almad et al., 2011). However, oligodendrocyte cell loss
continues progressively through apoptosis-mediated cell death
at subacute and chronic stages of SCI (Casha et al., 2001;
Grossman et al., 2001; Almad et al., 2011). Evidence shows
that oligodendrocytes are highly susceptible to cell death even
after moderate contusive injury resulting in the loss of over
90% of the oligodendrocytes at the lesion epicenter by seven
days after injury (McTigue et al., 2001). Interestingly, apoptotic
oligodendrocyte death is also observed chronically along the
long ﬁber tracts as a consequence of axonal degeneration
and loss of trophic support from axons (Crowe et al., 1997).
Similar process has been observed chronically in primate models
of contusive SCI (Crowe et al., 1997) and in human SCI
(Guest et al., 2005). Multiple secondary injury mechanisms
contribute to oligodendrocyte loss in SCI including digestion
by proteolytic enzymes released from damaged cells and toxic
blood components (Juliet et al., 2009), ischemic damage, and
oxidative stress (Thorburne and Juurlink, 1996; McAdoo et al.,
1999; Jana and Pahan, 2007), glutamate and ATP mediated
excitotoxicity (Wang et al., 2004; Xu et al., 2004; Gudz
et al., 2006; Matute et al., 2007), pro-inﬂammatory cytokines
released from inﬁltrated neutrophils and lymphocytes (Antel
et al., 1994; Popovich et al., 1997; Takahashi et al., 2003;
Demjen et al., 2004; Pineau and Lacroix, 2007; Donnelly and
Popovich, 2008; Kanno et al., 2009) and autophagy (Kanno et al.,
2009).
Despite extensive cell death, new oligodendrocytes form
and remyelination occurs spontaneously following SCI and
demyelinating CNS diseases (Chari, 2007; Zawadzka et al.,
2010). Mature oligodendrocytes are post-mitotic and unable to
contribute to cell renewal (Keirstead and Blakemore, 1997).
However, the spinal cord harbors a population of adult OPCs
that contribute to oligodendrocyte replacement following injury
(McTigue et al., 2001; Zawadzka et al., 2010). These OPCs
can be identiﬁed by the expression of platelet derived growth
factor receptor α (PDGFR-α) and NG2 proteoglycan (Levine and
Nishiyama, 1996; Keirstead et al., 1998; McTigue et al., 2001;
Schonberg et al., 2007). Recent ﬁndings have shown that resident
adult spinal cord OPCs become activated, and change their gene
transcription pattern resembling immature OPCs (Moyon et al.,
2015). OPCs diﬀerentiate into myelinating oligodendrocytes
and remyelinate spared axons following demyelination (Gensert
and Goldman, 1997; McTigue et al., 2001; Hesp et al.,
2015). In addition to OPCs, the spinal cord also contains a
population of endogenous NPCs, which is known to contribute
to oligodendrocyte replacement following injury (Horky et al.,
2006; Meletis et al., 2008; Barnabe-Heider et al., 2010; Karimi-
Abdolrezaee et al., 2012). These NPCs exist in the ependymal
layer of the intact spinal cord (Weiss et al., 1996; Barnabe-Heider
et al., 2010). In adulthood and under normal conditions, NPCs
are latent and their activity is mainly to maintain their own
population through self-renewal (Meletis et al., 2008; Barnabe-
Heider et al., 2010). However, upon injury, they become activated
and migrate to the site of injury where they can generate new
glial cells (Horner et al., 2000; Barnabe-Heider et al., 2010).
Studies by our group and others have demonstrated that activated
NPCs predominantly diﬀerentiate into astrocytes after SCI,
with limited number diﬀerentiating into new oligodendrocytes
(Mothe and Tator, 2005; Meletis et al., 2008; Barnabe-Heider
et al., 2010; Karimi-Abdolrezaee et al., 2012). Moreover, the
newly formed NPCs derived astrocytes contribute to glial scar
formation following SCI (Meletis et al., 2008; Sabelstrom et al.,
2013).
Recent studies have shown that limited ability of NPCs for
oligodendrocyte diﬀerentiation in SCI milieu may be attributed
to unavailability, or modiﬁed expression of essential growth
factors for oligodendrocyte development (Karimi-Abdolrezaee
et al., 2006; Gauthier et al., 2013). Several studies have
addressed this possibility by administering growth factors to
optimize the post-SCI microenvironment to support survival
and diﬀerentiation of transplanted and endogenous NPCs into
oligodendrocytes as well as remyelination (Karimi-Abdolrezaee
et al., 2006; Ohori et al., 2006; Furusho et al., 2012; Gauthier
et al., 2013). In our NPC transplantation studies in subacute
and chronic SCI, sustained infusion of a cocktail of growth
factors including EGF, bFGF, and PDGF-AA was able to
signiﬁcantly enhance the long-term survival of NPCs in the
injured spinal cord (Karimi-Abdolrezaee et al., 2006, 2010).
Importantly, transplanted NPCs were able to survive and
integrate within the host tissue and diﬀerentiate into mature
myelinating oligodendrocytes and remyelinated axons (Karimi-
Abdolrezaee et al., 2006). EGF and bFGF are known to play
essential role in NPC survival and proliferation (Weiss et al.,
1996). In vivo delivery of these growth factors into animal models
of contusive SCI was associated with increased proliferation in
ependymal layer where NPCs reside. However, despite increased
proliferative activity, no signiﬁcant change in oligodendrogenesis
were seen, which could be due to the lack of PDGF-AA in
this growth factor regimen (Kojima and Tator, 2000, 2002).
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PDGF-AA promotes the proliferation of glial progenitor cells
and can trigger diﬀerentiation and survival of newly formed
oligodendrocytes (Raﬀ et al., 1988; Butt et al., 1997). Moreover,
bFGF in synergy with PDGF can regulate proliferation of adult
OPCs (Lachapelle et al., 2002; Frost et al., 2003). Interestingly, a
developmental study on FGF receptor 1 and 2 double knockout
mice (Fgfr1−/−, Fgfr2−/−) showed normal OPC proliferation,
diﬀerentiation and initiation of myelination. However, these FGF
receptor null animals demonstrated defective myelin thickening
during postnatal period and remained defective throughout their
adulthood (Furusho et al., 2012). This evidence suggests that FGF
signaling can regulate myelin sheath thickness (Furusho et al.,
2012).
Mash1, a transcription factor known to promote neural
diﬀerentiation, have also been implicated in endogenous
oligodendrocyte diﬀerentiation (Parras et al., 2004; Ohori
et al., 2006). Retroviral induction of Mash1 expression in
endogenous spinal cord NPCs following SCI resulted in
increased oligodendrocyte diﬀerentiation and formation of
new oligodendrocyte progenitor cells following a complete
transection rat model of SCI. Although a small number of
new Mash1 expressing oligodendrocytes expressed markers of
mature oligodendrocytes, the majority of these cells remained
NG2+ expressing progenitor cells and did not fully mature into
myelinating oligodendrocytes even weeks after injury (Ohori
et al., 2006).
Neuregulin-1 (Nrg-1) is another growth factor known
to promote OPCs survival, migration, and diﬀerentiation
into mature myelinating oligodendrocytes (Vartanian et al.,
1999; Miller, 2002). Nrg-1 is known to play essential roles
in oligodendrocyte and SC myelination (Brinkmann et al.,
2008). Our group has recently demonstrated that the rapid
and long lasting downregulation of Nrg-1 following contusive
SCI is an underlying cause of inadequate oligodendrocyte
diﬀerentiation (Gauthier et al., 2013). Restoring the reduced
levels of Nrg-1 in the injured spinal cord enhanced tissue
preservation, oligodendrocyte diﬀerentiation of spinal
cord NPCs, and increased oligodendrocyte and axonal
survival following SCI (Gauthier et al., 2013). Collectively,
these studies show the necessity of micro-environmental
optimizations in order to improve endogenous and exogenous
replacement of oligodendrocytes and axon remyelination
following SCI.
Inhibition of Remyelination after SCI
Current evidence shows that remyelination is additionally limited
by inhibitory modiﬁcations in the post-SCI niche caused by
secondary injury mechanisms particularly in chronic SCI (Larsen
et al., 2003; Kuhlmann et al., 2008; Karimi-Abdolrezaee et al.,
2010; Lau et al., 2012; Lukovic et al., 2015). Newly formed
oligodendrocytes often fail to fully ensheath and myelinate the
injured spared axons following injury resulting in incomplete
remyelination (Salgado-Ceballos et al., 1998). These inhibitory
signals are primarily associated with myelin debris, activated glial
cells, and inﬁltrating leukocytes following injury (Ji et al., 2006;
Kotter et al., 2006; Fancy et al., 2009; Pohl et al., 2011; Plemel
et al., 2013; Smith et al., 2014; Tepavcevic et al., 2014).
Presence of myelin debris and insuﬃcient clearance
by microglia and macrophages contributes to incomplete
remyelination by inhibiting OPCs diﬀerentiation and maturation
in vitro and in vivo (Kotter et al., 2006; Nave, 2010; Plemel et al.,
2014). Recent in vitro studies by Plemel et al. (2013) indicate
that exposure to myelin debris prevents OPCs maturation and
their transition to a myelinating phenotype (Plemel et al., 2013).
This was demonstrated by a signiﬁcant decrease in the number
of mature oligodendrocytes and was accompanied by increased
expression of two proteins, namely inhibitor of diﬀerentiation
(ID) 2 and ID4 that are known to block oligodendrocyte
maturation (Plemel et al., 2013). It has been shown that myelin
clearance and remyelination become less suﬃcient with aging
due to changes in macrophage secretory and phagocytic activity
(Shields et al., 1999; Miron and Franklin, 2014). A study
using a technique known as “heterochronic parabiosis” where
the circulation of a young animal is infused into an older
animal, demonstrated improvements in remyelination in the
old animal which is presumably due to better functioning
of young circulating monocytes for myelin debris clearance
(Miron and Franklin, 2014). Myelin debris is a potent inhibitory
component of injured spinal cord that impairs regeneration and
remyelination. Thus, proper myelin clearance is an important
step for remyelination process (Kotter et al., 2006).
Other molecules and pathways known to inhibit myelination
include LINGO (leucine rich repeat and Ig domain-containing,
Nogo receptor interacting protein), Wnt signaling, and
Semaphorin 3A (Sema3A) (Ji et al., 2006; Fancy et al., 2009;
Ye et al., 2009; Syed et al., 2011; Boyd et al., 2013). LINGO-1
is a component of Nogo receptor signaling complex (Ji et al.,
2006). In a hemisection model of SCI, application of LINGO-1
antagonist (LINGO-1-Fc) promoted functional recovery (Ji et al.,
2006). Dysregulation of Wnt signaling in OPCs also inhibits
myelination during development and repair (Fancy et al., 2009;
Ye et al., 2009). Wnt signaling is activated in diﬀerentiating OPCs
following chemically induced demyelination and in samples
from MS patients (Fancy et al., 2009). Following demyelination,
upregulation of T-cell factor 4 (tcf4), a Wnt pathway mediator,
is signiﬁcantly upregulated in diﬀerentiating OPCs and inhibit
oligodendrocyte maturation and myelination (Fancy et al.,
2011). Similarly, Sema3A negatively aﬀects OPC maturation and
recruitment in demyelinating conditions (Syed et al., 2011). Its
level increases signiﬁcantly after SCI, reaching its peak at one
week following injury (Kaneko et al., 2006). Increased expression
of Sema3A has also been observed in MS and experimental
demyelination models (Piaton et al., 2011; Boyd et al., 2013).
Sema3A overexpression delays recruitment of OPCs to the
demyelination site through a chemo-repulsive mechanism
(Piaton et al., 2011). Use of Sema3A inhibitor improved tissue
preservation, remyelination and functional recovery following
SCI (Kaneko et al., 2006).
Collectively, these ﬁndings demonstrate that
endogenous remyelination was impeded by the inhibitory
microenvironment following injury and activated astrocytes
and microglia/macrophages seem to play pivotal roles in this
inhibition. We will discuss recent studies on the role of resident
glial cells and peripherally recruited immune cells in modulating
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oligodendrocyte replacement and remyelination following CNS
injury.
Role of Glial Cells in Myelination
Astrocytes and CNS Myelination
Astrocytes play critical role in several aspects of myelination in
pathologic CNS including clearance of myelin debris, modulating
the activity of oligodendrocytes, myelin maintenance, and
renewal (Sorensen et al., 2002; Kakinuma et al., 2004; Iacobas
and Iacobas, 2010; Moore et al., 2011; Siebert and Osterhout,
2011; Schulz et al., 2012; Bracchi-Ricard et al., 2013; Pendleton
et al., 2013; Skripuletz et al., 2013; Brambilla et al., 2014).
Using a cuprizone model of rodent demyelination, Skripuletz
et al. (2013) demonstrated that astrocytes contribute to the
clearance of myelin debris by inducing the recruitment of
microglia into demyelinated lesion sites (Skripuletz et al., 2013).
Astrocytes impose their modulatory eﬀects through upregulation
of CXCL10, a chemokine that is known to play a role in T-cell
chemoattraction in CNS autoimmune disorders such as MS
(Sorensen et al., 2002).
Intercellular connections between astrocytes and
oligodendrocytes are critical for the proper physiology
of oligodendrocytes. While there are no gap junctions between
oligodendrocytes themselves, they are connected to astrocytes
through gap junctions, which make oligodendrocytes indirectly
interconnected (Nagy et al., 1997, 2001; Menichella et al., 2003).
Evidence shows that gap junctions are essential for proper myelin
physiology in the CNS (Menichella et al., 2003). Four diﬀerent
types of connexins have been identiﬁed in oligodendrocytes
(Cx29, 32, 45, 47). Cx29, Cx32, and Cx47 are known to be
expressed by oligodendrocytes that in conjunction with Cx26,
30, 43 on astrocytes, form the astrocyte-oligodendrocyte gap
junction complex (Scherer et al., 1995; Altevogt et al., 2002;
Menichella et al., 2003; Nagy et al., 2007). Double knockout mice
models lacking Cx47 and Cx32 die postnatally due to severe
apoptotic oligodendrocyte death, hypomyelination, and axonal
degeneration (Menichella et al., 2003). This evidence suggests
a critical role for astrocyte and oligodendrocytes inter-cellular
signaling in myelin physiology.
Astrocytes provide trophic support to oligodendrocytes by
producing growth factors. In an ethidium bromide (EB) induced
rat model of spinal cord demyelination, Talbott et al. (2005) were
able to show despite recruitment of OPCs to the site of injury,
they failed to mature and remyelinate axons in the areas that
astrocytes were absent. Astrocytes are known to produce PDGF
and LIF, which are supportive for oligodendrocyte survival at
progenitor and mature stages, respectively (Barres et al., 1993;
Gard et al., 1995).
While supportive of myelination in the normal CNS,
astrocytes can play detrimental roles in CNS remyelination
following pathology (Rosen et al., 1989; Kakinuma et al., 2004;
Pendleton et al., 2013; Brambilla et al., 2014; Hammond et al.,
2014). Astrocytes contribute substantially to the extracellular
matrix of the CNS. Following injury, they are activated and form a
glial scar, which is inhibitory to the repair and regeneration of the
CNS. The inhibitory inﬂuence of scar is mediatedmainly through
chondroitin sulfate proteoglycans (CSPGs), which have known
inhibitory eﬀects on axonal regeneration, axonal conduction,
remyelination, and cellular therapies in SCI (Massey et al., 2008;
Karimi-Abdolrezaee et al., 2010, 2012; Haylock-Jacobs et al.,
2011; Lau et al., 2012; Cua et al., 2013; Cregg et al., 2014; for
review see Dyck and Karimi-Abdolrezaee, 2015). Our recent
evidence shows that CSPGs inhibit the ability of NPCs to
proliferate, spread their cell processes, survive and diﬀerentiate
into oligodendrocytes (Dyck et al., 2015). Degradation of
CSPGs with chondroitinase ABC promotes oligodendrocyte
diﬀerentiation and myelination of both transplanted NPCs
(Karimi-Abdolrezaee et al., 2010) and endogenous precursor cell
populations (Karimi-Abdolrezaee et al., 2012). The detrimental
eﬀect of CSPGs upregulation by astrocytes is also observed in
MS lesion where the CSPGs aggrecan, neurocan, and versican
as well as hyaluronan accumulate at the borders of active
demyelinating lesions (Back et al., 2005; Chang et al., 2012).
In vivo and in vitro observations have shown that CSPGs limit
the ability of OPCs to migrate, mature and myelinate axons
(Kuhlmann et al., 2008; Lau et al., 2012; Pendleton et al., 2013).
Removal of CSPGs is correlated with enhanced remyelination
in MS lesions (Lau et al., 2012). Collectively, these data identify
the inhibitory role of activated astrocytes and scar-associated
CSPGs, in modulating NPCs and OPCs integration, migration,
maturation and myelination in SCI and MS conditions (Dyck
and Karimi-Abdolrezaee, 2015). In addition to the inhibitory
ECM produced by astrocytes, reactive astrocytes can also be
detrimental to remyelination in demyelinated CNS through the
secretion of Endothelin-1 (Hammond et al., 2014). Endothelin-
1 is shown to inhibit the diﬀerentiation of OPCs into mature
myelinating oligodendrocytes through the activation of Notch
signaling.
Taken together, these data demonstrate the complex role of
astrocytes in the CNS. The presence of astrocytes is required
to produce healthy myelin, however, the detrimental eﬀects of
activated astrocytes and their production of inhibitory ECM
molecules following injury limits the ability of the CNS in self-
repair and axon remyelination. Thus, developing interventions
to moderate the inhibitory eﬀects of scar-associated molecules
is a vital therapeutic strategy for CNS repair and remyelination
following injury.
Macrophages/Microglia and CNS Myelination
Emerging evidence indicates that macrophages and microglia
also play critical roles in modulating demyelination and
remyelination through their antigen presenting ability and
production of cytokines, chemokines and growth factors (for
review see Gordon, 2003; Mosser, 2003; Martinez et al.,
2008). After CNS injury or infection, microglia/macrophages
undergo phonotypical changes and become polarized into pro-
inﬂammatory “classically activated” M1 or anti-inﬂammatory
“alternatively activated” M2 phenotypes (as reviewed by Mosser,
2003; Martinez et al., 2008; Kigerl et al., 2009). Although both M1
and M2 cell types are activated microglia/macrophages, they play
distinct roles in CNS injury and repair. Pro-inﬂammatory M1
microglia/microphages are characterized by the production of
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cytokines such as interleukin (IL)- 1β, IL-6, IL-12, tumor necrosis
factor (TNF)-α (Mosser, 2003; Cherry et al., 2014; Kroner et al.,
2014; Peferoen et al., 2015) and reactive oxygen and nitrogen
species such as nitric oxide (NO) (Mosser, 2003; Peferoen et al.,
2015). Conversely, M2 microglia/microphages are a source of
anti-inﬂammatory factors such as arginase-1 (Arg-1) and IL-10,
which are known for their role in the development of type
II adaptive immune responses (Anderson and Mosser, 2002;
Miron and Franklin, 2014). Generally, accumulating evidence has
identiﬁed a pro-regeneration role for M2 microglia/macrophages
including a supporting role in overcoming axonal growth
inhibition imposed by CSPGs and myelin debris (Kigerl et al.,
2009).
A recent study also demonstrated phonotypical changes
in macrophages/microglia following lysolecithin-induced
demyelination in mice (Miron et al., 2013). Using speciﬁc
M1/M2 markers, Miron et al. (2013) identiﬁed a “switch”
from M1 to M2 phenotype following demyelination.
This transformation occurred between day 3 to 10 post-
lysolecithin-induced demyelination when M1 dominant
population of CD68+ macrophages/microglia adopted a
M2 dominant phenotype identiﬁed by Arg-1 expression.
This time window was closely correlated with a regenerative
stage at which OPCs were recruited to the site of lesion,
and diﬀerentiated into mature myelinating oligodendrocytes
(Miron et al., 2013). Further in vitro and in vivo investigations
conﬁrmed a supportive role for M2 microglia/macrophages in
remyelination. Adding M2 conditioned media into OPCs
cultures increased oligodendrocyte diﬀerentiation and
maturation (Miron et al., 2013; Miron and Franklin, 2014).
Selective depletion of M1 macrophages by intralesional injection
of gadolinium chloride reduced the proliferation rate of
OPCs without aﬀecting their migration and remyelination
capacity. Interestingly, in a rat model of lysolecithin
demyelination, M2 depletion was associated with delayed
oligodendrocyte diﬀerentiation and nodal reconstruction
(Miron et al., 2013) suggesting the pro-myelinating role of M2
macrophages.
Activation of microglia through intraspinal injection of
lipopolysaccharide (LPS), a Toll-like receptor-4 (TLR-4) agonist,
caused a signiﬁcant increase in NG2+ cell proliferation and
oligodendrocyte diﬀerentiation. However, activating microglia
using intraspinal injection of zymosan, a TLR-2 agonist,
showed oligodendrocyte loss without increase in NG2+ cell
proliferation (Schonberg et al., 2007). Interestingly, the extent of
SC remyelination remained unaﬀected (Kotter et al., 2001). Of
note, these studies also revealed that the timing of macrophages
response is a key factor as the early presence of the macrophages
was important for remyelination while delayed macrophage
depletion did not impair remyelination (Kotter et al., 2001).
Several mechanisms have been proposed for the positive role
of macrophages in remyelination. Among the main proposed
mechanisms are removal of myelin debris (Ousman and David,
2000) and production of growth factors known to promote
oligodendrocyte diﬀerentiation such as Insulin like Growth
Factor (IGF)-1 and TGF-β1 (Hinks and Franklin, 1999;Woodruﬀ
and Franklin, 1999; Hsieh et al., 2004). However, recent studies
by Kotter et al. in demyelinating models suggest that failure in
remyelination is mainly attributed to the loss of macrophages-
derived promoting factors rather than their role in myelin
clearance since this function can be covered by the resident
microglia (Kotter et al., 2001; Miron et al., 2013).
Altogether, evidence indicates that the type of immune
response is a determining factor that can promote or inhibit
remyelination in demyelinating CNS lesions (as reviewed
by Mosser, 2003; Wee Yong, 2010). Accordingly, targeted
immunomodulatory strategies rather than complete anti-
inﬂammatory treatments appears to be a more eﬀective strategy
for promoting remyelination in autoimmune demyelinating
conditions such as MS. Further research was needed to
elucidate the mechanisms involved in immune response after
demyelinating CNS conditions and the factors that promote
remyelination (Jackson et al., 2011).
Schwann Cells and Spinal Cord Remyelination
Following SCI or demyelination, endogenous SCs invade the
injury site and contribute to remyelinating the demyelinated
axons (Blakemore, 1975; Bunge et al., 1994; Beattie et al.,
1997; Guest et al., 2005). SCs entry to the injured spinal
cord occurs during the ﬁrst week of injury in parallel to
clearance of myelin and glial debris by microglia/macrophages
(Bunge et al., 1994; Beattie et al., 1997). SCs enter through
dorsal funiculi via dorsal root entry zone or lateral funiculi
from the rootlets that become adhered to the lateral spinal
cord after injury (Jasmin et al., 2000). In chemical models
of demyelination in rodents, remyelination by endogenous
SCs and oligodendrocytes progress simultaneously and fully
myelinate demyelinated axons by 4 weeks following the insult.
However, the extent of oligodendrocytes remyelination is smaller
when compare to peripheral myelin formed by SCs and is
restricted to the edges of the lesion (Blakemore, 1975). The
limited degree of oligodendrocyte remyelination has been
attributed to the absence of astrocytes in chemically demyelinated
lesions, as oligodendrocytes are dependent on astrocytes for
remyelination (Blakemore, 1975; Blakemore and Patterson,
1975).
Entry of SCs to the injured spinal cord is normally limited
by glia limitans formed by astrocytes. Following insult, SCs
invade the spinal cord through the regions where glia limitans is
disrupted. When the glial limitans is re-established by astrocytes,
SC invasion becomes progressively limited (Blakemore, 1976).
Interestingly, studies have shown that oligodendrocytes gradually
replace SCs in remyelinated axons and the transition from
peripheral to central myelination occurs without any loss
of function (Jasmin et al., 2000). However, other studies
showed that SCs persist even chronically following SCI and
continue myelinating axons (Hill et al., 2003). Subsequent
studies investigated the transition from SCs to oligodendrocytes
remyelination and found no change in SC myelination despite
increasing oligodendrocyte myelination in EB and radiation
(X-EB) demyelination model (Gilson and Blakemore, 2002).
There is also evidence that transplantation of OECs, SCs,
and bone marrow stromal cells can promote migration of
SCs from dorsal roots into the injury site (Hill et al., 2006;
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Biernaskie et al., 2007). Therefore; enhanced remyelination or
other beneﬁcial eﬀects observed after cell transplantation can be
partially attributed to migrating SCs particularly in studies with
poor survival of transplanted cells. This evidence suggests that
SCs serve as emergency responders and protect demyelinated
spinal cord axons at the time when oligodendrocytes are unable
to remyelinate eﬃciently.
Cell-Based Strategies for Remyelination
after SCI
Over the past decade, eﬀorts from our group and others have
been made to enhance oligodendrocyte replacement after SCI
by cell transplantation or activating endogenous stem/progenitor
cells (Hofstetter et al., 2005; Keirstead et al., 2005; Karimi-
Abdolrezaee et al., 2006, 2010, 2012; Parr et al., 2008; Gauthier
et al., 2013; Sparling et al., 2015). Cell transplantation in
particular has shown promising results in enhancing SCI
repair through multiple mechanisms including cell replacement,
trophic support, immunomodulation, and remyelination (Ogawa
et al., 2002; Okano et al., 2003; Cummings et al., 2005; Hofstetter
et al., 2005; Karimi-Abdolrezaee et al., 2006, 2010; Rossi et al.,
2010; Tetzlaﬀ et al., 2011; Vaquero and Zurita, 2011; Hawryluk
et al., 2012, 2014). Using diﬀerent cell types (Table 1), these
studies have suggested that remyelination is a key mechanism in
promoting functional recovery following SCI and demyelinating
conditions (Karimi-Abdolrezaee et al., 2006; Sasaki et al., 2006;
Eftekharpour et al., 2007; Yasuda et al., 2011; Hawryluk et al.,
2014).
Neural Stem and Progenitor Cells
Potential of transplanting NPCs or glial progenitor cells in
promoting remyelination has been explored in a wide variety
of pathological conditions such as SCI, genetically myelin
deﬁcient rodent models, and MS (Karimi-Abdolrezaee et al.,
2006; Eftekharpour et al., 2007; Cao et al., 2010; Karimi-
Abdolrezaee et al., 2010; Sharp et al., 2010; All et al., 2012;
Sun et al., 2013; Hawryluk et al., 2014). These studies have
collectively demonstrated the ability of transplanted NPCs to
diﬀerentiate into myelinating oligodendrocytes and ensheath
demyelinated axons. Our studies in mutant Shiverer mice and
rat SCI revealed that NPC-derived oligodendrocytes integrate
with demyelinated and dysmyelinated axons and successfully
remyelinate them (Karimi-Abdolrezaee et al., 2006; Eftekharpour
et al., 2007) (Figure 2). When we transplanted brain-derived
NPCs into the spinal cord of subacutely injured rats, we
found that survival and oligodendrocyte diﬀerentiation of
NPCs was limited in the injury microenvironment (Karimi-
Abdolrezaee et al., 2006; Eftekharpour et al., 2007) Improving
the microenvironment of engrafted NPCs with a cocktail
of growth factors (EGF, bFGF, PDGF-AA) considerably
promoted their long-term survival, tissue integration, and
oligodendrocyte diﬀerentiation and remyelination (Karimi-
Abdolrezaee et al., 2006, 2010). Importantly, in adult Shiverer
mice transplanted with NPC, we found evidence of myelination
and normal reconstruction of the node of Ranvier in chronically
dysmyelinated axons (Eftekharpour et al., 2007). In the areas
that NPC-derived oligodendrocytes enwrapped and myelinated
the Shiverer axons, restoration of a normal conﬁguration
of paranodal and juxtaparanodal structures was achieved
accompanied by improved axonal function in myelinated axons
(Figure 2). Similarly, in our rat SCI studies, evidence of NPC-
derived remyelination was conﬁrmed with immunoelectron
microscopy against YFP expression in transplanted YFP-NPCs
(Karimi-Abdolrezaee et al., 2006). Of note, in these studies,
transplantation of NPCs resulted in improved locomotor
recovery evident by signiﬁcant improvements in BBB and grid
walking test as well as foot print analysis (Karimi-Abdolrezaee
et al., 2006).
Subsequent studies by Windrem et al. (2008) demonstrated
similar outcomes following transplantation of human glial
progenitor cells into the brain of immune-deﬁcient neonatal
Shiverer mice. In this study, transplanted cells successfully
diﬀerentiated into myelinating oligodendrocyte and functionally
myelinated the dysmyelinated host axons in forebrain and
brainstem (Windrem et al., 2008). In agreement with our studies,
immunohistological and electrophysiological evidence revealed
reconstruction of the node of Ranvier in transplanted neonatal
Shiverer mice and restoration of transcallosal conduction
velocity (Windrem et al., 2008). Moreover, transplanted mice
showed increased lifespan and decreased seizure rate, which
is frequently seen in Shiverer mice (Windrem et al., 2008).
Collectively, these studies provided proof-of-concept evidence
that NPC-derived oligodendrocytes can functionally remyelinate
chronically demyelinated axons in SCI and demyelinating
lesions.
Recent studies have provided further evidence that implicates
remyelination as a key mechanism for neurological improvement
observed after transplantation of NPCs in models of SCI
(Yasuda et al., 2011; Hawryluk et al., 2014). Yasuda et al. (2011)
transplanted Shiverer-derived NPCs that lack the capacity
for myelination into the injured spinal cord of NOD/SCID
immune-deﬁcient mice. Neuroanatomical, functional, and
electrophysiological analyses demonstrated better outcomes in
the injured mice transplanted with wild-type NPCs compared to
the mice that received Shiverer NPCs (Yasuda et al., 2011). This
work and similar study by Hawryluk et al. (2014) suggest that
remyelination is a key mechanism by which NPCs contributes to
the functional recovery following transplantation in SCI.
Genetically Modified NPCs for Remyelination
As mentioned earlier, in the post-SCI microenvironment,
transplanted stem cells exhibit limited capacity for survival
and migration and they primarily diﬀerentiate into astrocytes
at the expense of oligodendrocytes and neurons (Hofstetter
et al., 2005; Karimi-Abdolrezaee et al., 2006, 2010). Genetic
modiﬁcations in NPCs have been made to induce expression
of speciﬁc classes of transcription or growth factors in order
to enhance their survival and diﬀerentiation or modulate the
hostile microenvironment of SCI (Coumans, 2001; Linker
et al., 2002; Murray et al., 2002; Hwang et al., 2009; Yang
et al., 2009; Cao et al., 2010; Zhang et al., 2012). Using this
approach, impact of oligodendrocyte transcription factor,
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TABLE 1 | List of selected cell therapies for promoting remyelination following spinal cord injury (SCI) and multiple sclerosis (MS).
Reference Cell type Injury model Outcome
Hofstetter et al. (2005) Adult rat spinal cord NPCs
(Naïve or transduced to express
Neurogenin-2 )
Thoracic contusive rat SCI,
(Subacute)
Increased myelination and white matter sparing in
Ngn2-NPC group.
Improved BBB and grid-walking in Ngn2-NPC group.
Keirstead et al. (2005) hESC derived OPCs Thoracic contusive rat SCI,
(Subacute and chronic)
Significant remyelination occurred in subacute OPCs
transplantation.
Improved functional recovery was observed after
subacute transplantation.
Karimi-Abdolrezaee et al. (2006) Adult brain NPCs + growth
factor cocktail
Thoracic compressive SCI
(subacute and chronic)
Significant oligodendrocyte replacement and
remyelination in subacute transplantation (2 weeks
post-injury).
Significant functional improvement in subacute therapy
(BBB, grid-walking and footprint analysis).
Chronic transplantation was not successful (8 weeks
post-injury).
Karimi-Abdolrezaee et al. (2010) Adult brain NPCs + ChABC
and growth factors
Thoracic compressive SCI
(chronic)
Significant improvement in remyelination and functional
recovery in transplanted animals.
Eftekharpour et al. (2007) Adult brain NPCs adult Shiverer mice Myelination of chronically dysmyelinated axons
happened in transplanted group. Reconstruction of
nodes of Ranvier and enhanced axonal conduction.
Sasaki et al. (2006) Adult OECs from Adult rat model of spinal cord
X-EB demyelination
Transplanted OECs integrated with host tissue and
remyelinated axons. Nodes of Ranvier were
reconstructed and conduction velocity was significantly
restored.
Yasuda et al. (2011) Adult NPCs derived from
wild-type or Shiverer mice
Thoracic contusive SCI in adult
NOD/SCID mice
Both cell types survived after transplantation and
exhibited similar differentiation potential. Only wild-type
NPC group demonstrated preserved or enhanced
myelination and significant functional and
electrophysiological recovery.
Hawryluk et al. (2014) Adult mice brain NPCs from
wild-type or Shiverer mice
Rat thoracic contusive SCI
using 23 g clip compression
Shiverer NPC transplanted group showed no significant
remyelination and no significant change in functional
recovery while wild-type NPC transplanted group
demonstrated significant remyelination by transplanted
cells and significant functional recovery.
Kumagai et al. (2009) Primary and secondary
neurospheres (PNS and SNS)
from CCV-ES cell line derived
NPCS
Mouse thoracic contusive SCI PNS and SNS survived in host tissue.
Transplanted SNS but not PNS showed remyelination,
axonal regeneration and functional recovery.
Sharp et al. (2010) hESC derived OPCs Rat cervical midline contusive
SCI
Significant white and gray matter sparing.
Significantly higher properly oligodendrocyte
remyelinated axons.
Sun et al. (2013) mESC derived OPCs Radiation induced rat cervical
spinal cord demyelination
Transplanted cells survived and integrated into the host
tissue, migrated to the injured tissue and differentiated
into oligodendrocytes. Improvement of forelimb
locomotor function.
Windrem et al. (2008) Human GRPs Neonatal Shiverer mice cross
bred with immune-deficient
rag2 null mice
Multifocal anterior and posterior fossa delivery of
hGRPs showed significant improvement in survival,
neurological function and seizure frequency in neonatal
Shiverer mice.
Hwang et al. (2009) hNPCs expressing Olig2 Adult rat contusive SCI Transplanted animals exhibited enhanced myelination in
white matter and improved functional recovery.
Cao et al. (2010) CNTF expressing adult rat
spinal cord OPCs
Thoracic contusive SCI Enhanced remyelination and functional recovery in
transplanted animals.
Utzschneider et al. (1994) Adult spinal cord glial cells Neonatal congenitally myelin
deficient rats
Improvement in conduction velocity of axons in
transplanted region was observed.
Walczak et al. (2011) Human glial restricted
progenitors
Adult rat chemical focal
demyelination model and
neonatal rag2−/−shiverer mice
Transplanted rats showed preserved
electrophysiological conduction across spinal cord.
Despite extensive remyelination in neonatal Shiverer
mice marginal myelination observed in transplanted
adult rats.
(Continued)
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TABLE 1 | Continued
Reference Cell type Injury model Outcome
Totoiu et al. (2004) Neonatal mouse glial
committed progenitors
Mouse HMV induced CNS
demyelination
Remyelination in transplanted animals was evident with
significant axonal preservation and locomotor recovery.
Hatch et al. (2009) hESC derived OPCs JHMV induced CNS
demyelination
Transplanted cells failed to survive beyond 2 weeks.
Focal remyelination and subtle functional recovery was
observed that was attributed to inflammatory
modulation and trophic support provided by
transplanted cells.
Piao et al. (2015) hESC derived OPCs Athymic nude rat model of
radiation induced brain
demyelination
Transplantation to several spots along cerebellum and
forebrain showed significant remyelination and cognitive
and motor improvement.
Imaizumi et al. (2000) Adult OECs or Schwann cells
(SCs) from pigs expressing
human complement inhibitory
protein, CD59
Adult rat dorsal column
transection
Remyelination of demyelinated axons was observed
with improvement in conduction velocity in transplanted
animals.
Radtke et al. (2004) Adult porcine OECs EBr or lysophosphatidyl choline
induced demyelination in
African green monkey spinal
cord
Transplanted cells integrated with host tissue and
remyelinated axons.
Boyd et al. (2004) LacZ expressing OECs injected
into the cystic cavity
Rat model of thoracic contusive
SCI
Transplanted cells did not migrate from the injection
site. SCs migrated into the cystic cavity.
No direct evidence of remyelination by LacZ labeled
OECs was observed. OECs mainly enveloped groups of
axons myelinated by SCs.
Sasaki et al. (2011) Rat OECs Rat model of X-EB induced
spinal cord demyelination
(acute and subacute)
Transplanted cells integrated with host tissue and
remyelinated axons. Reconstruction of nodes of
Ranvier and improved axonal conduction velocity were
achieved. Remyelination was higher in acutely
transplanted group.
Tsuji et al. (2010) MEF-iPSCs derived NPCs Mouse model of contusive SCI Transplanted cells showed multilineage differentiation
into oligodendrocytes, astrocytes and neurons.
Wang et al. (2013) Human skin derived iPSC
derived OPCs
Shiverer mice neonatal brain Transplanted cells integrated with host tissue and
differentiated into astrocytes and MBP expressing
oligodendrocytes. Shiverer axons were remyelinated
and node of Ranvier was reconstructed. No
tumorigenicity was observed. Increased lifespan of
Shiverer mice was observed.
Nori et al. (2011) hiPSC derived neurospheres Thoracic contusive SCI in
NOD-SCID mice
Grafted cells differentiated into neurons, astrocytes and
oligodendrocytes. Myelin content of the tissue was
increased with significantly better functional recovery in
transplanted group.
Kobayashi et al. (2012) hiPSC-NS/PCs Adult
common marmoset primate
model of contusive SCI
Improved functional recovery in open field, bar grip and
cage climbing tests in transplanted group.
Olig2 has been investigated in myelin physiology and repair.
Olig2 is known to play important role in oligodendrocyte
diﬀerentiation during development (Takebayashia et al.,
2000). Using a contusive model of rat SCI, Hwang et al.
(2009) demonstrated that retroviral overexpression of Olig2
in transplanted F3 human NPCs enhanced oligodendrocyte
replacement accompanied by a signiﬁcant increase in white
matter sparing, decreased lesion size, increased myelin
thickness and improved locomotor recovery compared to
non-transduced F3 NPCs. In another study, using transgenic
mice overexpressing Olig2 in SOX10+ oligodendrocytes,
Wegener et al. (2015) conﬁrmed that Olig2 overexpression
enhanced OPC diﬀerentiation, maturation, and migration
as well as remyelination following chemical demyelination.
Studying demyelinated lesions in human MS brain samples
revealed that Olig2+ remyelinating oligodendrocytes are more
abundantly present in active lesion borders compared to chronic
plaques (Wegener et al., 2015). This evidence identiﬁes a role
for Olig2 in promoting oligodendrocyte diﬀerentiation and
remyelination.
A neuroprotective role for ciliary neurotrophic factor (CNTF)
in enhancing oligodendrocyte diﬀerentiation and maturation has
been established in the CNS and PNS (Hagg and Varon, 1993;
Linker et al., 2002; Naumann et al., 2003). Genetic modiﬁcations
in adult rat spinal cord OPCs to express CNTF attenuated
oligodendrocyte apoptosis resulting in improved survival,
maturation and myelinating capacity of OPCs (Cao et al., 2010).
CNTF expressing OPCs transplanted rats also showed signiﬁcant
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FIGURE 2 | Transplanted adult NPCs (aNPCs) promote the aggregation
of K+ channels and the formation of nodes of Ranvier in the spinal
cord axons of shi/shi mice. Confocal immunostaining of Kv1.2 subunits
(red) and pan-Na+ hannels (blue) in the spinal cord of wild-type mice (A–C),
control shi/shi mice (G–I), and transplanted shi/shi mice (M–P) is depicted.
Kv1.2 subunits were clearly localized to the juxtaparanodal regions of
wild-type spinal cord axons (A–C), confirmed with nodal pan-Na+
immunostaining. In shi/shi mice, Kv1.2 immunostaining was abnormally
distributed along the axonal internodes (G–I), but Na+ clusters were
observed as aberrant nodal aggregates. Six weeks after aNPCs
transplantation, spinal cord segments of shi/shi mice showed restoration of
Kv1.2 subunit clusters (M–P). YFP-positive processes of transplanted aNPCs
were observed in close association with axons containing restored K+
channels aggregates (P). Nodal localization of Na+ channels was further
confirmed using Nav1.6 (red) immunostaining in wild-type (D–F), control
shi/shi (J–L), and transplanted shi/shi (Q–T). Caspr (blue) immunostaining
was used to identify the paranodal area. A 3D reconstruction clearly shows a
node of Ranvier that is bordered by an MBP-expressing NPC derived
oligodendrocyte. Note that the processes of YFP-labeled oligodendrocytes
avoid the nodal region (U). From Eftekharpour et al. (2007).
improvements in their axonal signal conduction and hind limb
locomotor recovery compared to the group that received normal
OPCs (Cao et al., 2010).
Altogether, current evidence suggests that NPCs can be
engineered to act as environmental modulators in addition
to their role in cell replacement. This strategy presents
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a therapeutic avenue for improving microenvironment and
optimizing the outcome of cell transplantation in CNS trauma
and demyelinating diseases.
Glial-Restricted and OPCs
Due to challenges with oligodendrocyte diﬀerentiation of NPCs,
transplantation of diﬀerentiated glial-restricted precursors (GRP)
and OPCs has been pursued in SCI and demyelinating conditions
(Utzschneider et al., 1994; Keirstead et al., 2005; Walczak et al.,
2011; Sun et al., 2013). Early studies demonstrated the potential
of bi-potential O2A progenitor cells for diﬀerentiation into
oligodendrocytes or type 2 astrocytes (De Los Monteros
et al., 1993). When postnatal O2A progenitor cells, genetically
modiﬁed to express β-galactosidase, were transplanted into
the spinal cord following x-ray induced demyelination,
they showed the capacity to form oligodendrocytes and
successfully remyelinated axons in demyelinated lesion
(Groves et al., 1993). Interestingly, no evidence of astrocyte
diﬀerentiation was observed after transplantation of O2A
progenitors (Groves et al., 1993) suggesting the inﬂuence
of demyelinated host tissue on cell fate speciﬁcation of
transplanted cells. Successful remyelination also achieved
following transplantation of brain-derived mouse GRPs into the
spinal cord of mice with virally induced demyelination lesion
that was associated with improved functional recovery (Totoiu
et al., 2004).
Application of OPCs has also shown promising results
in supporting remyelination. The potential of human ESC
derived OPCs for remyelination has been evaluated in animal
models of SCI and demyelination (Keirstead et al., 2005; Sharp
et al., 2010; Piao et al., 2015). These studies uncovered that
subacute stage of injury is the optimal time window for OPCs
transplantation in the context of traumatic SCI. Keirstead
et al. (2005) compared remyelination and functional recovery
following transplantation of hESC derived OPCs at 7 days
(subacute) and 10 months (chronic) after contusive SCI in
rats. Subacute transplantation was associated with successful
remyelination by transplanted OPCs and functional recovery
while chronic transplantation did not improve remyelination
(Keirstead et al., 2005). In this study, contribution of invading
SCs to remyelination was also assessed (Keirstead et al.,
2005). The number of SC-remyelinated axons was signiﬁcantly
increased in injured animals and decreased to normal levels
after transplantation of hESC derived OPC. In order to quantify
the contribution of SCs and OPCs in remyelination, authors
relied on the diﬀerence in the thickness of myelin to diﬀerentiate
between central vs peripheral myelination. However, use of
immunological labeling for SCs or ultrastructural criteria of SC
myelination would be a more precise approach to determine
the contribution of SCs in spinal cord remyelination after
injury. In addition to SCs, endogenous OPCs and NPCs also
contribute to remyelination which was not investigated in this
study.
One important outcome of the Keirstead study was the
inability of transplanted OPCs to remyelinate chronically
demyelinated axons despite their survival and the capacity to
diﬀerentiate into oligodendrocytes (Keirstead et al., 2005). This
evidence suggests the inherited inhibitory nature of chronic
lesions for axonal ensheathment and remyelination. Interestingly,
our groups observed the same outcomes after transplantation
of NPCs in chronic SCI (Karimi-Abdolrezaee et al., 2006). Our
subsequent studies revealed that dense deposits of CSPGs in
the chronic glial scar is a potent limiting factor to survival,
integration, oligodendrocyte diﬀerentiation, and remyelination
of both endogenous and transplantedNPCs (Karimi-Abdolrezaee
et al., 2010, 2012; Dyck et al., 2015). As described in earlier
sections, removal of CSPGs by ChABC allowed NPC-mediated
remyelination of chronically demyelinated spinal cord axons.
These studies suggest that successful application of OPCs or
NPCs in chronic SCI requires multifaceted interventions to
modulate the inhibitory milieu of the established glial scar.
Although other factors may play a role in this inhibition, CSPGs
seems to be a major obstacle (Dyck and Karimi-Abdolrezaee,
2015).
Eﬃcacy of transplanted OPCs has also been investigated in
chronic demyelinating conditions. Transplantation of mouse
ESC derived OPCs into a radiation induced rat model of
cervical spinal cord demyelination 4 months after radiation
therapy, showed successful survival, and migration of these
cells toward the lesion and their capacity for oligodendrocyte
remyelination (Sun et al., 2013). Moreover, signiﬁcant myelin
and tissue preservation as well as improved forelimb locomotor
function were observed in OPC transplanted animals (Sun et al.,
2013). Transplantation of hESC derived OPCs transplanted
into athymic nude rat model of radiation induced brain
demyelination, promoted remyelination of the demyelinated
brain and cerebellum and ameliorated cognitive and motor
deﬁcits in the injured animals, with no evidence of tumor
formation following transplantation (Piao et al., 2015).
Absence of neuronal diﬀerentiation and insigniﬁcant astrocyte
diﬀerentiation in transplanted cells indicates a deﬁning role for
remyelination by oligodendrocytes in white matter repair and
cognitive and motor improvement (Piao et al., 2015).
In addition to their role in replacing remyelinating
oligodendrocytes, OPCs are known to enhance axo-neuronal
growth and survival by producing growth factors such as
brain derived neurotrophic factor (BDNF), IGF-1, glial derived
growth factor (GDNF), neuregulins (NRGs), and neurotrophins
(Du and Dreyfus, 2002; Dai, 2003; Wilkins et al., 2003) that
potentially contributed to the functional improvement observed
in these studies. Based on current evidence, transplanted OPCs
or NPCs have additional beneﬁts beyond their known role
in cell replacement and myelination including improving the
host environment with providing trophic support and their
immunomodulatory eﬀects.
Olfactory Ensheathing Cells
Olfactory ensheathing cells (OECs) have been extensively
examined for their potential for remyelination after SCI and
demyelinating lesions (Ramon-Cueto and Nieto-Sampedro,
1994; Imaizumi et al., 2000; Kato et al., 2000; Akiyama et al.,
2004; Radtke et al., 2004; Boyd et al., 2005; Sasaki et al.,
2006, 2011; Lankford et al., 2008, 2014; Radtke, 2008; Tabakow
et al., 2013). OECs are supporting cells that ensheath the
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axons of olfactory neurons. They have become a popular
choice for cell transplantation due to their accessibility. Unlike
oligodendrocytes or SCs, OECs do not normally myelinate axons
in the nervous system (Sasaki et al., 2011). However, evidence
suggests that following transplantation into the injured CNS,
OECs demonstrate the ability to remyelinate axons and can
promote functional recovery in animal models of SCI (Imaizumi
et al., 2000; Kato et al., 2000; Akiyama et al., 2004; Radtke et al.,
2004; Sasaki et al., 2006, 2011; Lankford et al., 2008; Radtke, 2008;
Tabakow et al., 2013; Lankford et al., 2014).
Studies by Sasaki et al. (2011) showed evidence of
remyelination by transplanted rat OECs in a rat model of
X-EB induced demyelination in the thoracic spinal cord.
Unlike chemical demyelination, X-EB models allow long lasting
demyelination due to elimination of oligodendrocytes and
astrocytes in the lesion area; therefore, excluding the potential
contribution of endogenous myelinating cells. In this model,
remyelination by transplanted OECs was investigated after
acute and subacute OECs transplantation. Engrafted OECs were
shown to integrate with the host tissue and remyelinated axons
with predominant characteristic of P0 peripheral myelination
(Sasaki et al., 2006). Immunoelectron microscopy at 2 and
3 weeks following transplantation conﬁrmed OECs-derived
remyelination of host demyelinated axons and reconstruction
of the normal organization of the nodes of Ranvier (Sasaki
et al., 2006). Functionality of OEC remyelination was conﬁrmed
by improved conduction velocity through electrophysiological
recording of the spinal cords at 3 weeks after transplantation
(Sasaki et al., 2006). While considerable myelination was
observed following both acute and subacute lesions, the extent
of myelination was considerably higher in acutely transplanted
group (Sasaki et al., 2006).
Another study in nonhuman primate demonstrated the
ability of OECs to remyelinate spinal cord axons following
demyelination lesions (Radtke et al., 2004). In this study, porcine
OECs were transplanted into chemically induced demyelinated
adult female African green monkey spinal cord 3 days after
the induction of lesion (Radtke et al., 2004). Evidence of
remyelination was observed at 3-5 weeks after transplantation in
62.5% of the transplant recipients. Endogenously remyelinated
axons were evident in the vicinity of OECs-myelinated axons
in the lesion while no remyelination was observed in non-
transplanted group at this time-point. However, this study was
not able to clearly distinguish between OECs and SCs derived
remyelination (Radtke et al., 2004).
Since SCs and OECs demonstrate similar characteristics, their
behavior and response have been compared in demyelinated
spinal cord in co-transplantation studies (Lankford et al., 2008,
2014). Interestingly, these studies suggest distinct migratory and
proliferative properties for OECs compared to SCs. Lankford
et al. (2008) injected a mixture of SCs and OECs at 1 week after
X irradiation into the rat spinal cord. Only transplanted OECs
migrated through white and gray matter of the irradiated spinal
cord. Four weeks after transplantation, a new EB demyelination
was induced in the spinal cord. Tissue analysis revealed that “pre-
loaded” OECs but not SCs were able to migrate toward the new
EB lesion and populate the demyelinated site. Subsequent studies
by the same induced demyelination using X irradiation in the
juvenile rats hippocampus conﬁrmed a better migratory ability
for OECs in populating the lesion compared to SCs similar to
the pattern observed in the adult host (Lankford et al., 2008,
2014).
While extensive evidence suggests a direct role for
OECs in axonal ensheathing and remyelinating, there are
also some reports that have questioned their myelinating
capability in SCI (Takami et al., 2002; Boyd et al., 2004).
Boyd et al. (2004), using Lacz expressing OECs, were able
to track transplanted OECs in the spinal cord of injured
rats. While labeled OECs were evident in the lesion at
3 weeks post-transplantation, electron micrographs of the
injured spinal cord showed no direct evidence of axonal
ensheathment and myelination by LacZ labeled OECs
(Boyd et al., 2004). Transplanted LacZ labeled OECs
mainly enveloped a group of axons myelinated by SCs.
The authors concluded that OECs support SCI repair by
other mechanisms such as providing permissive substrate
for axon growth and SC remyelination (Boyd et al., 2004).
In contrast to these observations, another study using
superparamagnetic iron oxide labeling demonstrated the
ability of both transplanted SCs and OECs for remyelination
in X-EB spinal cord demyelination (Dunning et al., 2004).
Subsequently, Dombrowski et al. (2006) transplanted GFP
expressing OECs into the injured sciatic nerve and using
immunoelectron microscopy showed that transplanted GFP+
OECs formed peripheral type myelin around axons. However,
one question that remained undetermined in these studies
was the degree of SC contamination in their OEC culture.
Degree of SCs contamination in OEC cultures is an important
consideration that may underlie diﬀerent outcomes seen in these
studies.
Regardless of their direct role in axonal remyelination, OECS
are shown to recondition injury environment by producing
a host of trophic factors including NGF, BDNF, and CNTF
that can support endogenous repair (Ramon-Cueto and Avila,
1998; Chuah and West, 2002; Martin et al., 2002; Au and
Roskams, 2003). Studies have shown that transplanted OECs
enhance functional recovery through enhanced angiogenesis and
immunomodulatory eﬀects at acute and subacute stages post-
transplantation (López-Vales et al., 2005). López-Vales et al.
(2005) demonstrated that transplantation of OECs results in
upregulation of Cox-2 and vascular endothelial growth factor
(VEGF) following SCI.
Collectively, while application of OECs has shown promising
results in experimental models of SCI and demyelination, the
ability of OECs for CNS remyelination is still a matter of debate
due to their similarities with SCs and potential contamination
of OEC cultures with SCs. Further in vitro and in vivo
studies using speciﬁc markers of OECs and SCs is required to
speciﬁcally distinguish these two cell populations and conﬁrm the
myelinating capacity of OECs.
Induced Pluripotent Stem Cells
While cell translation is a promising approach for enhancing
remyelination following injury, graft rejection due to the host
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immune reaction poses a major challenge to the success
of cell-based therapies (Nakamura and Okano, 2013).
Successful transplantation in animal models has required
immunosuppression, wherein chance of the graft rejection
had been minimized using immunosuppressive therapy
or genetically immune-deﬁcient models (Cummings et al.,
2005; Karimi-Abdolrezaee et al., 2006, 2010). Importantly,
immune reaction is a hallmark of pathologic CNS that plays
essential roles in tissue injury and repair (Eyo and Dailey,
2013; Cherry et al., 2014). Hence, use of autologous sources of
stem cells seems to be a logical solution to warrant the long-
term survival of transplanted cells without compromising
the host CNS immune response. Moreover, autologous
transplantation preclude ethical and technical limitations in
using embryonic stem cells or fetal derived tissues that has been
a major hurdle in translating this promising repair strategy
into clinical arenas (Lo and Parham, 2009; Zarzeczny and
Caulﬁeld, 2009; Nakamura and Okano, 2013; King and Perrin,
2014).
Generation of induced pluripotent stem cells (iPSCs) using
autologous somatic cells has opened new avenues for developing
clinically feasible cell transplantation approaches (Saito et al.,
2005; Takahashi and Yamanaka, 2006; Yamanaka and Takahashi,
2006; Qi and Pei, 2007; Yamanaka, 2008; Nagy, 2009; Zhou
et al., 2010; Liu et al., 2012; Nguyen et al., 2014). Since the
introduction of iPSCs technology in stem cell research, several
studies have explored the therapeutic potential of transplanting
iPSCs-derived NPCs or OPCs in SCI for inducing remyelination
as well as the safety of this approach with regards to tumorigenesis
(Miura et al., 2009; Tsuji et al., 2010; Nori et al., 2011; Kobayashi
et al., 2012; Wang et al., 2013). Tsuji et al. (2010) transplanted
allogenic NPCs generated from mouse embryonic ﬁbroblast
(MEF)-derived iPSCs into a mouse model of contusive SCI at
9 days post injury. The safety of this approach was previously
conﬁrmed by observing no teratoma formation after 24 weeks
of transplantation into NOD/SCID mouse brain (Miura et al.,
2009). Six weeks following transplantation, MEF-iPSC derived
NPCs showed multilineage capacity and diﬀerentiated into
oligodendrocytes, astrocytes, and neurons (Tsuji et al., 2010).
Functional analysis suggested improved neurological recovery in
the transplanted animals, which was accompanied by enhanced
remyelination as well as regeneration of the raphe-spinal ﬁbers
in transplanted animals (Tsuji et al., 2010). Similar observations
have been made using a variety of adult tissue derived iPSCs
(Nakamura and Okano, 2013). Transplantation of selected non-
tumorigenic clone of adult tail tip ﬁbroblast derived iPSCs
into a mouse model of contusive SCI resulted in signiﬁcant
functional recovery (Tsuji et al., 2010; Nakamura and Okano,
2013). In mouse (Nori et al., 2011) and primate (Kobayashi
et al., 2012) models of SCI, transplanted NPCs derived from
human adult facial skin derived iPSCs were able to diﬀerentiate
into neurons, oligodendrocytes, and astrocytes which resulted
in enhanced functional recovery accompanied by axonal growth
(Nori et al., 2011; Kobayashi et al., 2012; Nakamura and Okano,
2013).
Remyelination has been considered as a mechanism
underlying the functional improvement observed in iPSCs
transplantation strategies (Wang et al., 2013). A recent study
by Wang et al. (2013) demonstrated that transplanted OPCs
generated from autologous skin derived human iPSCs of
keratinocyte and ﬁbroblast origin, were able to diﬀerentiate into
mature myelinating oligodendrocytes and myelinate human
fetal cortical neurons in vitro (Wang et al., 2013). In immune-
deﬁcient Shiverer mice, human iPSC-derived OPCs integrated
with the host neonatal brain tissue after transplantation,
diﬀerentiated to MBP expressing oligodendrocytes, remyelinated
the dysmyelinated Shiverer axons, and constructed the nodes of
Ranvier (Wang et al., 2013). No tumorigenicity was observed in
this study and transplanted Shiverer mice exhibited increased
lifespan (Wang et al., 2013).
Taken together, emerging evidence shows the potential and
feasibility of transplanting iPSCs derived NPCs and OPCs for
promoting oligodendrocyte replacement and remyelination in
demyelinating conditions such as MS and traumatic CNS injury.
While promising, the risk of tumorigenicity and proper cell
diﬀerentiation of this therapy have yet remained to be carefully
investigated. In Table 1, we have listed cell therapies that have
been developed to promote oligodendrocytes replacement and
remyelination after SCI and MS conditions.
Conclusion
The myelin sheath is an essential component in the CNS and
PNS that ensures rapid signal transduction in axons through
the nervous system. Myelinated ﬁbers show a highly specialized
and organized structure at the node of Ranvier that is vital
to their proper functioning. Damage to oligodendrocytes due
to trauma or disease results in demyelination that causes
aberrant localization and expression of ion channels associated
with axonal dysfunction. Although considerable remyelination
occurs spontaneously by endogenous CNS progenitor cells,
the quality and extend of myelination is not optimal to
restore structural and physiological properties of injured axons.
Emerging research evidence has uncovered several mechanisms
by which oligodendrocyte diﬀerentiation and remyelination are
regulated within the microenvironment of injury. Inhibitory role
of activated glial cells and insuﬃcient expression of promoting
factors are major limiting factors that impede remyelination.
Over the past years, extensive research eﬀorts have been
made to therapeutically promote remyelination following CNS
trauma or demyelinating disease. Outcomes of the recent
pharmacological and cell-based therapies indicate the impact
of remyelination as a mechanism for improving function
after injury. Further investigations are needed to develop
eﬀective and feasible repair strategies with potential for clinical
translation.
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